With difamilast ointment (Adquey) approved as a PDE4B-preferential inhibitor, how do you differentiate among topical PDE4 inhibitors (difamilast vs roflumilast vs crisaborole) when selecting initial nonsteroidal therapy for atopic dermatitis? Do you have any real-world experience with difamilast?